The information in this preliminary prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
SUBJECT TO COMPLETION, DATED DECEMBER 17, 2020
PRELIMINARY PROSPECTUS
$200,000,000
Altimeter Growth Corp. 2
20,000,000 Shares
Altimeter Growth Corp. 2 is a blank-check company incorporated as a Cayman Islands exempted company, which was incorporated to consummate a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. In this prospectus, we refer to such business combination as our initial business combination. We have not selected any business combination target and we have not – nor has anyone on our behalf – initiated any substantive discussions with any business combination target. In identifying and acquiring a business combination target, we will not be limited to any particular industry or geographic region.
This is an initial public offering of our Class A ordinary shares, par value $0.0001 per share, which we refer to as our public shares, at an initial public offering price per share of $10.00. The underwriters have a 45-day option from this prospectus date to buy up to 3,000,000 additional public shares to cover over-allotments, if any. Unlike other initial public offerings of special purpose acquisition companies, investors in this offering will not receive any warrants (which would typically become exercisable following completion of our initial business combination).
Our public shareholders may redeem all or a portion of their Class A ordinary shares upon our initial business combination’s completion, subject to the limitations, terms, and conditions as described in this prospectus. If we have not consummated an initial business combination within 24 months from this offering’s closing (or within 27 months of this offering’s closing if we have executed a letter of intent, agreement in principle, or definitive agreement for our initial business combination within that 24-month time period, but we have not completed our initial business combination within such 24-month time period), then we will redeem 100% of the public shares for cash, subject to applicable law and certain conditions as described in this prospectus.
Our sponsor, Altimeter Growth Holdings 2 (an affiliate of Altimeter Capital Management, LP), has agreed to buy 600,000 Class A ordinary shares (or 660,000 Class A ordinary shares if the underwriters’ over-allotment option is exercised in full) at a price of $10.00 per share, in a private placement that will close concurrently with this offering’s closing. The private placement shares are identical to the Class A ordinary shares sold in this offering, subject to certain limited exceptions as described in this prospectus.
(“ ”) is a , and is affiliated both with our sponsor and with Altimeter Capital Management, LP, and will enter into a forward purchase agreement with us before this offering’s closing. Under the forward purchase agreement, has committed to buy from us – and we have the right to sell and issue to – up to forward purchase shares for $10.00 per share, or an aggregate purchase price of in a private placement that would close substantially concurrently with our initial business combination’s closing. We will determine in our sole discretion the specific number of forward purchase shares that we sell to , if any. The forward purchase shares will be identical to the Class A ordinary shares being sold in this offering, except that they will be subject to certain registration rights, as described herein. The forward purchase agreement provides that may decline to purchase some or all of the forward purchase shares if our sponsor and our sponsor’s affiliates collectively own 25% or more of our outstanding shares when we initiate the private placement sale of forward purchase shares.
Our sponsor is the initial shareholder and currently owns 5,750,000 Class B ordinary shares, up to 750,000 of which are subject to forfeiture depending on the extent to which the underwriters’ over-allotment option is exercised. The Class B ordinary shares will automatically convert into Class A ordinary shares upon our initial business combination or earlier at the option of the holders thereof as described in this prospectus. Before our initial business combination, only holders of our Class B ordinary shares will be entitled to vote to appoint directors. On any other matter submitted to a vote of our shareholders, holders of the Class B ordinary shares and holders of the Class A ordinary shares will vote together as a single class, except that in a vote to continue the Company in a jurisdiction outside the Cayman Islands, holders of Class B ordinary shares will have ten votes per share and holders of Class A ordinary shares will have one vote per share, and except as required by law or the applicable rules of The New York Stock Exchange, or the “NYSE,” then in effect.
Currently, there is no public market for our Class A ordinary shares. We intend to apply to have our public shares listed on the NYSE under the symbol “AGCB” on or promptly after this prospectus date.
We are an “emerging growth company” under applicable federal securities laws and will be subject to reduced public company reporting requirements.
Investing in our securities involves a high degree of risk. See “Risk Factors” beginning on page
30 for a discussion of information that should be considered in connection with an investment in our securities. Investors will not be entitled to protections normally afforded to investors in Rule 419 blank check offerings.
Neither the Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
Public offering price | | | $10.00 | | | $200,000,000 |
Underwriting discounts and commissions(1) | | | $0.55 | | | $11,000,000 |
Proceeds, before expenses, to us | | | $9.45 | | | $189,000,000 |
(1)
| Includes $0.35 per public share, or $7,000,000 in the aggregate (or $8,050,000 in the aggregate if the underwriters’ over-allotment option is exercised in full), payable to the underwriters for deferred underwriting commissions to be placed in a trust account located in the United States as described in this prospectus and released to the underwriters only upon the closing of an initial business combination. See also “Underwriting” for a description of compensation and other items of value payable to the underwriters. |
Of the proceeds we receive from this offering and the sale of the private placement shares described in this prospectus, $200,000,000, or $230,000,000 if the underwriters’ over-allotment option is exercised in full ($10.00 per public share in either case), will be deposited into a U.S.-based trust account with Continental Stock Transfer & Trust Company acting as trustee.
The underwriters are offering the shares for sale on a firm commitment basis. The underwriters expect to deliver the shares to the purchasers on or about , 2021.
Book-Running Managers
Citigroup | | | Goldman Sachs & Co. LLC | | | Morgan Stanley |
The date of this prospectus is , 2021